2021
DOI: 10.1016/j.tmaid.2021.102096
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 and Dengue virus co-infection: A case from North Caribbean Colombia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 6 publications
(13 reference statements)
0
5
0
Order By: Relevance
“…[ 19 ] Conversely, mosquito-borne dengue fever is characterized by mild to moderate grade fever accompanied by vomiting, rashes, aches, and body-ache with the alarm sign as blood vomit. 20 , 21 Despite this, published case reports from different countries have found patients with similar clinical presentations and comparable laboratory findings in blood pictures, except for a frequently lowered platelet count in COVID-19 and Dengue coinfection, 22 , 23 , 24 , 25 , 26 however in our case we found the platelet count was within normal range. There are concerns regarding potential cross-reactivity between these two viruses, serodiagnostic tests for Dengue virus may yield many false-positive results for non-severe SARS-CoV-2 and vice versa in dengue-endemic regions.…”
Section: Discussionmentioning
confidence: 52%
“…[ 19 ] Conversely, mosquito-borne dengue fever is characterized by mild to moderate grade fever accompanied by vomiting, rashes, aches, and body-ache with the alarm sign as blood vomit. 20 , 21 Despite this, published case reports from different countries have found patients with similar clinical presentations and comparable laboratory findings in blood pictures, except for a frequently lowered platelet count in COVID-19 and Dengue coinfection, 22 , 23 , 24 , 25 , 26 however in our case we found the platelet count was within normal range. There are concerns regarding potential cross-reactivity between these two viruses, serodiagnostic tests for Dengue virus may yield many false-positive results for non-severe SARS-CoV-2 and vice versa in dengue-endemic regions.…”
Section: Discussionmentioning
confidence: 52%
“…In the case of countries, such as Bolivia and Paraguay, is particularly curious that they have not reported most of the neglected arboviral pathogens, although have been described in most of their neighboring countries. Neglected Arboviruses in Latin America DOI: http://dx.doi.org/10.5772/intechopen.108940 A significant problem in the diagnosis of these arboviruses includes the clinical and epidemiological overlapping [4], even with possible coinfections [16,22,98], but also the problems derived from potential antibody cross-reactivity that may yield serological false-positive results, now even, including coinfections and cross-reactivity with SARS-CoV-2 [18,[99][100][101][102]. Then, molecular diagnosis of them is critical, including multiplex testing to search simultaneously many arboviruses and perform more specific serological testing, using better antigens, such as plaque reduction neutralizing antibody testing (PRNT) [103], especially in patients with risks for severe or complicated disease.…”
Section: Rocio (Rocv)mentioning
confidence: 99%
“… 1 , 2 The convergence of these two diseases in the same space and time raised awareness about a potential syndemic, where the interaction between both conditions worsens the health outcomes. 3 Currently, several cases of co-infections with COVID-19 and dengue virus (DENV) have been reported around the world, 4 7 including in countries that share the Amazon Basin, such as Brazil, 8 Colombia, 9 and Peru. 10 Both acute viral diseases—DENV and COVID-19—can be fatal for patients, and we know little about the impact of co-infection on diagnosis, prognosis, severity, and sequelae.…”
Section: Introductionmentioning
confidence: 99%